Fundely
3137
Axel Mark
3624
Twenty-four seven
7074
Visumo
303A
Nomura Micro Science
6254
(FY)Sep 30, 2024 | (FY)Sep 30, 2023 | (FY)Sep 30, 2022 | (FY)Sep 30, 2021 | (FY)Sep 30, 2020 | |
---|---|---|---|---|---|
Operating cash flow (Indirect Method) | |||||
Cash from operating activities | 145.93%52.29M | 74.07%-113.84M | -67.64%-438.99M | 66.09%-261.87M | -772.15M |
Net profit before non-cash adjustment | 737.11%169.22M | 91.23%-26.56M | 6.96%-302.96M | 57.24%-325.6M | ---761.49M |
Total adjustment of non-cash items | 67.33%36.9M | 166.69%22.05M | -211.96%-33.07M | 73.01%-10.6M | ---39.28M |
-Depreciation and amortization | 301.39%63.05M | 1,330.69%15.71M | 20.26%1.1M | -72.18%913K | --3.28M |
-Reversal of impairment losses recognized in profit and loss | --3.05M | --0 | -78.37%838K | -31.49%3.87M | --5.66M |
-Other non-cash items | -560.40%-29.2M | 118.12%6.34M | -127.49%-35M | 68.09%-15.39M | ---48.22M |
Changes in working capital | -40.70%-153.83M | -6.18%-109.33M | -238.53%-102.97M | 159.65%74.33M | --28.63M |
-Change in receivables | -46.20%-167.7M | -403.83%-114.71M | 64.15%-22.77M | -212.43%-63.51M | ---20.33M |
-Change in inventory | -1,417.22%-74.2M | 112.53%5.63M | -1,909.30%-44.94M | -93.03%2.48M | --35.66M |
-Change in payables | 48.91%32.27M | -27.37%21.67M | -44.31%29.84M | 802.72%53.58M | ---7.62M |
-Provision for loans, leases and other losses | -81.63%515K | 672.04%2.8M | -148.32%-490K | --1.01M | ---- |
-Changes in other current assets | 323.60%55.29M | 61.73%-24.73M | -179.98%-64.6M | 286.01%80.77M | --20.92M |
Dividends paid (cash flow from operating activities) | |||||
Dividends received (cash flow from operating activities) | |||||
Interest paid (cash flow from operating activities) | 2.85%-4.05M | 11.10%-4.17M | -14.11%-4.69M | -113.28%-4.11M | -1.93M |
Interest received (cash flow from operating activities) | 766.67%78K | -18.18%9K | 37.50%11K | 14.29%8K | 7K |
Tax refund paid | -332.08%-2.29M | 76.86%-530K | 0.00%-2.29M | -131.31%-2.29M | -990K |
Other operating cash inflow (outflow) | -100.01%-1K | 11.21M | 0 | 0 | 109.8M |
Operating cash flow | 142.88%46.02M | 75.93%-107.33M | -66.24%-445.97M | 59.67%-268.27M | ---665.26M |
Investing cash flow | |||||
Net PPE purchase and sale | -95.54%-10.03M | 3.46%-5.13M | -15.54%-5.32M | 91.07%-4.6M | ---51.5M |
Net intangibles purchase and sale | -76.65%-191.58M | -955.39%-108.45M | ---10.28M | --0 | ---- |
Net investment product transactions | ---29.57M | --0 | ---- | ---- | ---- |
Net changes in other investments | -216.28%-300K | 125.80%258K | -112.61%-1M | -52.28%7.93M | --16.62M |
Investing cash flow | -104.26%-231.48M | -583.05%-113.33M | -597.78%-16.59M | 109.56%3.33M | ---34.87M |
Financing cash flow | |||||
Net issuance payments of debt | --0 | ---100M | --0 | 31.71%270M | --205M |
Net common stock issuance | -95.39%21.42M | --464.26M | --0 | 31,269.81%846.99M | --2.7M |
Issuance fees | --0 | ---17.02M | --0 | ---- | ---- |
Net other fund-raising expenses | 217,000.00%2.17M | ---1K | ---- | ---- | ---- |
Financing cash flow | -93.21%23.59M | --347.24M | --0 | 437.79%1.12B | --207.7M |
Net cash flow | |||||
Beginning cash position | 14.94%971.17M | -35.36%844.92M | 187.89%1.31B | -52.00%454.05M | --945.98M |
Current changes in cash | -227.87%-161.87M | 127.37%126.59M | -154.29%-462.56M | 273.03%852.05M | ---492.43M |
Effect of exchange rate changes | -514.74%-2.13M | -204.85%-346K | -68.42%330K | 109.42%1.05M | --499K |
Cash adjustments other than cash changes | 50.00%-1K | -100.00%-2K | -200.00%-1K | --1K | ---- |
End cash Position | -16.89%807.17M | 14.94%971.17M | -35.36%844.92M | 187.89%1.31B | --454.05M |
Free cash flow | 29.57%-155.59M | 52.14%-220.91M | -69.15%-461.56M | 61.93%-272.87M | ---716.75M |
Currency Unit | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |